Arpida Revenue and Competitors
Estimated Revenue & Valuation
- Arpida's estimated annual revenue is currently $7M per year.
- Arpida's estimated revenue per employee is $201,000
Employee Data
- Arpida has 35 Employees.
- Arpida grew their employee count by -22% last year.
Arpida's People
| Name | Title | Email/Phone |
|---|
Arpida Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Arpida?
Arpida (SIX: ARPN) is a biopharmaceutical company headquartered in Reinach, near Basel, Switzerland with operations in Switzerland and the USA. It focuses on novel drugs that seek to overcome the growing problem of microbial resistance. Arpida's leading product candidate is intravenous iclaprim, an antibiotic that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
keywords:N/A
N/A
Total Funding
35
Number of Employees
$7M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arpida News
2022-02-22 - ?eské Bud?jovice: Díky Centru Arpida si Honza (31) plní sny!
Podobn? to má i Jan Hlavá? (31), kterého u 27 let posouvá kup?edu organizace Arpida. Plní si tu svoje sny. P?estoe je kv?li t?kému t?lesnému...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.1M | 35 | 9% | N/A |
#2 | $9.1M | 35 | -8% | N/A |
#3 | $2.9M | 35 | -5% | N/A |
#4 | $6.9M | 35 | 3% | N/A |
#5 | $15M | 35 | 35% | N/A |